In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.